Showing results (31-40 of 63) with videos related to
Sort By:
Pageof 7
Protein Engineering|February 1, 1995
Introduction of lysine residues on the light chain constant domain improves the labelling properties of a recombinant Fab fragmentA Hemminki, A M Hoffrén, K Takkinen, et al.Gene Therapy|March 5, 2004
A cyclooxygenase-2 promoter-based conditionally replicating adenovirus with enhanced infectivity for treatment of ovarian adenocarcinomaA Kanerva, G J Bauerschmitz, M Yamamoto, et al.Nature Genetics|December 1, 1994
Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancerA Hemminki, P Peltomäki, J P Mecklin, et al.Cancer Gene Therapy|January 20, 2007
A three-dimensional assay for measurement of viral-induced oncolysisJ T Lam, A Hemminki, A Kanerva, et al.Veterinary and Comparative Oncology|October 11, 2014
Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsiesK Autio, A Knuuttila, A Kipar, et al.Gene Therapy|July 2, 2003
Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinomaS D Barker, I P Dmitriev, D M Nettelbeck, et al.Cancer Research|May 30, 1998
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumorsE Avizienyte, S Roth, A Loukola, et al.Gynecologic Oncology|September 5, 2001
Transcriptional targeting for ovarian cancer gene therapyE Casado, D M Nettelbeck, J Gomez-Navarro, et al.Gene Therapy|March 23, 2007
Luciferase imaging for evaluation of oncolytic adenovirus replication in vivoK Guse, J D Dias, G J Bauerschmitz, et al.Gene Therapy|November 11, 2011
Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4J D Dias, O Hemminki, I Diaconu, et al.Pageof 7